Adoption of new drugs by physicians: a survival analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Health Policy
Link
http://link.springer.com/article/10.1186/1472-6963-12-56/fulltext.html
Reference25 articles.
1. Wun YT, Chan CS, Dickinson JA: Determinants of physicians' attitude towards prescribing. J Clin Pharm Ther. 2002, 27: 57-65. 10.1046/j.1365-2710.2002.00389.x.
2. Buusman A, Andersen M, Merrild C, Elverdam B: Factors influencing GPs' choice between drugs in a therapeutic drug group. A qualitative study. Scand J Prim Health Care. 2007, 25: 208-213. 10.1080/02813430701652036.
3. Mason A: New medicines in primary care: a review of influences on general practitioner prescribing. J Clin Pharm Ther. 2008, 33: 1-10. 10.1111/j.1365-2710.2008.00875.x.
4. Steffensen FH, Sorensen HT, Olesen F: Diffusion of new drugs in Danish general practice. Fam Pract. 1999, 16: 407-413. 10.1093/fampra/16.4.407.
5. Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH: Timing of new black box warnings and withdrawals for prescription medications. JAMA. 2002, 287: 2215-2220. 10.1001/jama.287.17.2215.
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Analysis of belimumab prescription and outcomes in a 10-year monocentric cohort: is there an advantage with early use?;RMD Open;2024-04
2. Adoption of new medicines in primary care: A comparison between the uptake of new oral anticoagulants and diabetes medicines;British Journal of Clinical Pharmacology;2023-12-04
3. Trends in tuberculosis clinicians’ adoption of short-course regimens for latent tuberculosis infection;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2023-12
4. Strengthening Warfighter Resiliency Using Broad-Spectrum or Host-Directed Therapies within the Rapid Acquisition and Investigation of Drugs for Repurposing Program;Journal of Pharmacology and Experimental Therapeutics;2023-10-12
5. Use and Cost of Sustained-Release Corticosteroids for Cataract Surgery Under the Medicare Pass-Through Program;JAMA Ophthalmology;2023-09-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3